CyMedica Orthopedics said it has launched a clinical trial to evaluate the effectiveness of its E-vive muscle-strengthening device and patient engagement system in knee osteoarthritis patients.
Researchers will combine the data generated by the E-vive neuromuscular electrical stimulation device with the activity and health data collected by commercially available wearable smartwatch devices to determine the effect of E-vive on improving patient osteoarthritis (OA) symptoms, according to Scottsdale, Ariz.-based CyMedica.
Get the full story on our sister site, Medical Design & Outsourcing.